THE EFFECT OF METHOXYFLURANE on the sensitivity of the heart to epinephrineinduced ventricular arrhythmias has not been clearly defined. On the one hand, animal experiments have been reported which found that methoxyflurane increases ventricular arrhythmias associated with epinephrine administration. 1,~ On the other hand, other studies have found that methoxyflurane protects against arrhythmias? ,4 Still other reports have found methoxyflurane to be less sensitizing than cyclopropane or halothane, but as sensitizing as chloroform or halothaneether azeotrope. 5,6 That epinephrine can be safely injected subcutaneously to secure haemostatis during operations performed under methoxyflurane 7-15 is a unanimous ff pragmatic observation. It is an observation, however, which neither defines the risk, ff any, involved in such a practice, nor contributes to our understanding of the pharmacological properties of methoxyflurane.
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The present study was undertaken to evaluate under controlled conditions in experimental animals (1) the effect of methoxyflurane on ventricular sensitivity to epinephrine-induced arrhythmias, and (2) the effect of methoxyflurane on severity of ventricular arrhythmias produced by epinephrine. The former was determined by measuring the effect of methoxyflurane on the time required for appearance of ventricular arrhythmias during the continuous infusion of a standard, dilute solution of epinephrine. The latter was measured as the effect of methoxyfiurane on duration of ventricular arrhythmias produced by epinephrine. Duration of ventrieular arrhythmias was equated with severity on the basis that one or two abnormal ventricular contractions are not of the same significance as well established, continuing abnormal contractions.
M~.a~aODS
Nine unanaesthetized, unmedicated mongrel dogs weighing between 12.5 and 22.5 kg were paralysed with succinylcholine to permit insertion of cuffed endotracheal tubes. Respirations were controlled by a non-rebreathing constant volume respirator set to deliver 4 L/min of 100 per cent oxygen. A thin-walled 16 gauge needle was inserted into an external jugular vein of each dog and a dilute (1 mg/ml) solution of succinylcholine was infused at the rate of 1 mg/min to main-*Dr. Burleigh was a medical student research fellow while carrying out this research. Dr. Greene is professor of anesthesiology at the Division of Anesthesiology, Yale University School of Medicine, and the Department of Anesthesiology, Yale New Haven Medical Center, New Haven, Connecticut. Address reprint requests to Dr. Nicholas M. Greene, 789 Howard Ave., New Haven, Conn. 06504. 341
Canad. Anaesth. Soc. J., vol. 17, no. 4, July 1970 tain paralysis. A plastic intravenous tube was used to connect a 20 ml syringe containing a dilute epinephrine solution (0.1 mg/ml) to the distal end of the suecinylcholine infusion tubing. The syringe was placed in a pump, set to deliver 1.0 ml/min when turned on. Electrocardiogram needles were inserted into the right forepaw and the left hind leg. A Grass Polygraph was used to record standard lead 2 ECG tracings from these at a paper speed of 250 era/rain.
Each dog was allowed to stabilize until ECC tracings showed only normal sinus rhythm for at least 15 rain as deternained by ECr monitoring. The experiment thereafter was divided into two parts, with each animal serving as its own control.
Part one consisted of infusion of epinephrine into the paralysed but unanaesthetized dog using a technique similar to that of Meek et al., 16 but at a rate of 0.1 mg/min while the ~.ce was continuously monitored. The infusion was continued until a ventricular arrhythmia appeared (premature ventricular contraction, ventricular tachycardia, or ventricular fibrillation). The infusion was then immediately stopped but the ECr recording continued until regular sinus rhythm was restored. Time of onset of ventricular arrhythmias was defined as the interval between initiation of the epinephrine infusion and appearance of the first ventri- A period of 30 minutes was allowed for inactivation of infused epinephrine 17 before proceeding to part two of the experiment. Part two consisted of introducing between the oxygen supply and the respirator a constant temperature (Pentec) vaporizer set to deliver 1.0 per cent methoxyflurane. After rnethoxyflurane had been administered for 25 minutes, the epinephrine infusion was again started at the rate of 0.1 mg/min and allowed to continue with continuous ECC monitoring until the first ventricular arrhythmia appeared. The infusion was then stopped and the ECG continued until sinus rhythm was re-established. Time of onset and duration of arrhythmias were determined as in part one. Because of the long duration of action of methoxyflurane the sequence of the experiments was not reversed.
Differences in time of onset and duration of arrhythmias between parts one and two were analysed using Student's t-test, statistical significance being assumed when p values were 0.05 or less.
PtESULTS
The types of arrhythmia produced are summarized in Table I, time of onset in  Table 1I , and duration in Table III 
DlsctlSSlON
Previous studies of the effect of methoxyflurane on sensitivity of the heart to epinephrine-induced ventricular arrhythmias have been concerned either with comparisons made between the effect of methoxyflurane and the effect of other inhalation anaesthetics, 1.4-~ or with the effect of methoxyflurane on the response to single intravenous injections of epinephrine2 , 18 The former studies give important comparative data but do not define the effect of methoxyflurane per se. The latter by relying upon the single injection of a standard amount of epinephrine make the determination of sensitivity thresholds in individual animals impossible because the amount of epinephrine injected may be in excess of the minimum amount required to produce an arrhythmic effect. The present study permits evaluation of the effect of methoxyflurane by comparing the response to epinephrine under only two conditions: in the presence and absence of methoxyflurane. It also permits determination of the effect of methoxyflurane on sensitivity thresholds to the arrhythmic effect of epinephrine by using each dog as its own control and by continuously infusing dilute epinephrine at a constant rate in the presence and absence of methoxyflurane until arrhythmias are produced. Further, it is the only report of the effect of methoxyflurane on duration of ventricular arrhythmias produced by epinephrine.
The results of our investigation indicate that methoxyflurane has no significant effect either on the sensitivity of the canine heart to epinephrine or on the duration of epinephrine-induced arrhythmias. Methoxyflurane, therefore, neither protects the heart from the arrhythmic effect of epinephrine nor sensitizes it to the drug. These results agree with the laboratory fndings of Van Poznak and A_rtusio 8 as well as with the uncontrolled clinical studies reported by others, r-15
On the basis of the present data, methoxyflurane is the inhalation anaesthetic of choice when epinephrine is to be used either by subcutaneous injection to achieve local haemostasis or by intravenous infusion to support a failing heart by virtue of its positive inotropie and ehronotropie effect. This is in contrast to tri-chlorethylene and halothane anaesthesia, when intravenous epinephrine is contraindicated and when subcutaneous injections are recommended only in very dilute solutions. 19,2~ It is also in contrast to cyclopropane anaesthesia, when epinephrine is contraindicated in any amount by any route, ea SUMMa_aY Methoxyflurane anaesthesia in dogs had no significant effect on time of onset or duration of ventricular arrhythmias produced by continuous infusion of epinephrine. It is concluded that methoxyflurane neither protects nor sensitizes the canine myocardium to epinephrine. It is suggested that methoxyflurane is the inhalation anaesthetic of choice when epinephrine is employed.
R~;SUM~;
L'anesthrsie au mrthoxyflurane chez les chiens n'a pas eu d'effet apprrciable sur le moment du drbut ou sur la durre des arythmies ventriculaires produites par une infusion continue d'rpinrphrine. On peut conclure que le mrthoxyflurane ne protrge nine sensibilise le myocarde des chiens ~t l'rpinrphrine. On est d'avis que, parmi les anesthrsiques par inhalations, de mrthoxyflurane est ranesthrsique de choix lorsque l'rpin~phrine est utilisre.
